Nemera

    OverviewSuggest Edit

    Nemera is a company that designs, develops, and manufactures drug delivery devices for the pharmaceutical, biotechnology, and generic industries. Its services and products cover different application areas such as ophthalmic, nasal, dermal, parenteral, and inhalation.
    TypePrivate
    Founded2014
    HQLa Verpillière, FR
    Websitenemera.net
    Employee Ratings3.5

    Latest Updates

    Employees (est.) (Jul 2021)799(+3%)
    Cybersecurity ratingBMore

    Nemera Office Locations

    Nemera has offices in La Verpillière, Le Tréport, Buffalo Grove and Neuenburg am Rhein
    La Verpillière, FR (HQ)
    20 Avenue de la Gare
    Le Tréport, FR
    17 Route d'Eu
    Neuenburg am Rhein, DE
    Rheinwaldstraße 10
    Buffalo Grove, IL, US
    600 Deerfield Pkwy
    Show all (4)

    Nemera Financials and Metrics

    Summary Metrics

    Founding Date

    2014

    Nemera Cybersecurity Score

    Cybersecurity ratingPremium dataset

    B

    82/100

    SecurityScorecard logo

    Nemera Online and Social Media Presence

    Embed Graph

    Nemera Blogs

    Nemera presents its pen injector’s offer to reach customers and patients’ needs

    From our platforms to your pen injector Parenteral administration has several significant advantages such as better bioavailability, faster onset of effect, more predictable pharmacokinetic and pharmacodynamic profiles and avoiding the first-pass effect. For self-injected drugs, the user interface p…

    Nemera is happy to announce the launch of Novelia as Lunah by Cristalia on Brazilian market

    Cristália launches Lunah in brazilian market. Cristália, one of the largest pharmaceutical companies in Brazil, launched LUNAH, a preservative-free artificial tears, through its ophthalmology division Latinofarma. Announced in an online event for 2,000+ physicians, LUNAH was launched in the brazilia…

    Nemera expands its insulin pen’s offer in Brazil

    Nemera and Biomm sign partnership agreement to commercialize reusable insulin pen in Brazil This partnership expands offer of diabetes medicines in the country; Nemera’s Advapen launch happens under the trade name Lifepen® for the administration of Glargilin insulin for the treatment of diabetes A p…

    Going the extra mile to tackle dermal delivery challenges

    Know more about our Dermal Round Table The dermal application is a convenient non-invasive way to administer liquid sprays, lotions, gels, or creams to the skin for dermatological, anti-inflammatory or systemic treatments. We have been working in the dermal field for the past two decades, producing …

    Nemera breaks ground in Brazil through Milfra acquisition

    Nemera breaks ground in Brazil through Milfra acquisition With this acquisition Nemera establishes an operational footprint in Brazil and expands its product and services offering to better serve the pharmaceutical industry in Latin America. Nemera today announced that they have entered into an agre…

    How to correctly use a nasal spray?

    Collaboration with several ENT specialits on patient education therapy Allergic rhinitis is a symptomatic disorder of the nose induced after exposure to allergens via Immunoglobulin-E (IgE)-mediated hypersensitivity reactions. Currently, approximately 10 to 30% of adults and 40% of children are affe…
    Show more

    Nemera Frequently Asked Questions

    • When was Nemera founded?

      Nemera was founded in 2014.

    • How many employees does Nemera have?

      Nemera has 799 employees.

    • Who are Nemera competitors?

      Competitors of Nemera include West Pharmaceutical Services, Phillips-Medisize and ab medica.

    • Where is Nemera headquarters?

      Nemera headquarters is located at 20 Avenue de la Gare, La Verpillière.

    • Where are Nemera offices?

      Nemera has offices in La Verpillière, Le Tréport, Buffalo Grove and Neuenburg am Rhein.

    • How many offices does Nemera have?

      Nemera has 4 offices.